SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia.

Gorman, KM; Meyer, E; Grozeva, D; Spinelli, E; McTague, A; Sanchis-Juan, A; Carss, KJ; Bryant, E; Reich, A; Schneider, AL; et al. Gorman, KM; Meyer, E; Grozeva, D; Spinelli, E; McTague, A; Sanchis-Juan, A; Carss, KJ; Bryant, E; Reich, A; Schneider, AL; Pressler, RM; Simpson, MA; Debelle, GD; Wassmer, E; Morton, J; Sieciechowicz, D; Jan-Kamsteeg, E; Paciorkowski, AR; King, MD; Cross, JH; Poduri, A; Mefford, HC; Scheffer, IE; Haack, TB; McCullagh, G; Deciphering Developmental Disorders Study; UK10K Consortium; NIHR BioResource; Millichap, JJ; Carvill, GL; Clayton-Smith, J; Maher, ER; Raymond, FL; Kurian, MA (2019) Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia. Am J Hum Genet, 104 (5). pp. 948-956. ISSN 1537-6605 https://doi.org/10.1016/j.ajhg.2019.03.005
SGUL Authors: Southgate, Laura Jamshidi, Yalda

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (331kB) | Preview
[img]
Preview
PDF (Supplemental material) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (4MB) | Preview

Abstract

The occurrence of non-epileptic hyperkinetic movements in the context of developmental epileptic encephalopathies is an increasingly recognized phenomenon. Identification of causative mutations provides an important insight into common pathogenic mechanisms that cause both seizures and abnormal motor control. We report bi-allelic loss-of-function CACNA1B variants in six children from three unrelated families whose affected members present with a complex and progressive neurological syndrome. All affected individuals presented with epileptic encephalopathy, severe neurodevelopmental delay (often with regression), and a hyperkinetic movement disorder. Additional neurological features included postnatal microcephaly and hypotonia. Five children died in childhood or adolescence (mean age of death: 9 years), mainly as a result of secondary respiratory complications. CACNA1B encodes the pore-forming subunit of the pre-synaptic neuronal voltage-gated calcium channel Cav2.2/N-type, crucial for SNARE-mediated neurotransmission, particularly in the early postnatal period. Bi-allelic loss-of-function variants in CACNA1B are predicted to cause disruption of Ca2+ influx, leading to impaired synaptic neurotransmission. The resultant effect on neuronal function is likely to be important in the development of involuntary movements and epilepsy. Overall, our findings provide further evidence for the key role of Cav2.2 in normal human neurodevelopment.

Item Type: Article
Additional Information: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: CACNA1B, developmental and epileptic encephalopathy (DEE), epilepsy, epilepsy-dyskinesia, Adolescent, Calcium, Calcium Channels, N-Type, Child, Child, Preschool, Dyskinesias, Epilepsy, Female, Humans, Infant, Loss of Heterozygosity, Male, Mutation, Pedigree, Synaptic Transmission, Deciphering Developmental Disorders Study, UK10K Consortium, NIHR BioResource, Humans, Epilepsy, Dyskinesias, Calcium, Calcium Channels, N-Type, Pedigree, Synaptic Transmission, Mutation, Loss of Heterozygosity, Adolescent, Child, Child, Preschool, Infant, Female, Male, Genetics & Heredity, 06 Biological Sciences, 11 Medical and Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Am J Hum Genet
ISSN: 1537-6605
Language: eng
Dates:
DateEvent
2 May 2019Published
11 April 2019Published Online
4 March 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
RP-2016-07-019Department of HealthUNSPECIFIED
R01 NS069605NINDS NIH HHSUNSPECIFIED
R00 NS089858NINDS NIH HHSUNSPECIFIED
RG/10/17/28553British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
WT098051Wellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/L010305/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
HICF-1009-003Health Innovation Challenge FundUNSPECIFIED
PubMed ID: 30982612
Web of Science ID: WOS:000466608700013
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113708
Publisher's version: https://doi.org/10.1016/j.ajhg.2019.03.005

Actions (login required)

Edit Item Edit Item